Literature DB >> 835564

Intensive hepatitis surveillance in Minnesota: methods and results.

B S Levy, J Mature, J W Washburn.   

Abstract

After a large foodborne outbreak of hepatitis A in April 1974, the Minnesota Department of Health attempted to improve ongoing hepatitis surveillance with a system based on 1) a large centralized blood bank, which reports results of tests for hepatitis B surface antigen (HBsAg) on suspected hepatitis patients; 2) private physicians, who are encouraged to report cases; and 3) an epidemiology aide, who contacts all detected patients and their physicians. During the first year of this system, we detected 932 cases (24.5 per 100,000), a threefold increase over previous years, and obtained detailed epidemiologic data on each case. Although physicians diagnosed 61% of these cases as hepatitis A (or non-B) and 39% as hepatitis B, they tested only 53% of all patients for HBsAg. Sixty-seven per cent of the tested patients were HBsAg-positive, but only 17% of the untested patients had illnesses diagnosed by physicians as hepatitis B. This suggests that many patients with clinically-diagnosed viral hepatitis who are not tested for HBsAg may be erroneously diagnosed by physicians as having non-B hepatitis. Thirty-three per cent of HBsAg-positive patients with known occupations, not including housewives and students, worked in meidcally-related occupations. For 51% of the HBsAg-positive patients, we could not identify recent parenteral exposure to hepatitis B.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835564     DOI: 10.1093/oxfordjournals.aje.a112364

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

1.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont.

Authors:  R L Vogt; D LaRue; D N Klaucke; D A Jillson
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

2.  Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States.

Authors:  J J Sacks
Journal:  Am J Public Health       Date:  1985-12       Impact factor: 9.308

3.  Distribution of antibody to hepatitis A antigen in a population of commerical plasma doners.

Authors:  W T Hall; F K Mundon; D L Madden; D DeSouza; J L Kane
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

4.  Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.

Authors:  P Baur; V Daniel; S Pomer; H Scheurlen; G Opelz; D Roelcke
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.